Clinical trialNCT04796012RecruitingPhase 1/PHASE2Interventional

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

SponsorUniversity of Texas Southwestern Medical CenterEnrollment23RhabdomyosarcomaSolid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Arhanti Sadanand, MD
University of Texas Southwestern Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Elizabeth Sokol, MD
Recruiting
Boston Children'S Hospital
Boston, Massachusetts, United States
Natalie Collins, MD
Recruiting
Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
Brian Turpin, DO
Recruiting
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Theodore Laetsch, MD
Recruiting
the University of Texas Southwestern Medical Center
Dallas, Texas, United States
Recruiting
Texas Children'S Hospital
Houston, Texas, United States
Shoba Navai, MD
Recruiting
Seattle Children'S
Seattle, Washington, United States
Katie Albert, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Apr 2023
Primary completion: 31 Jan 2027
Completion: 31 Jan 2027
Last update posted: 2 Jun 2026
Registered enrollment: 23
Registry id: NCT04796012

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.